Vascular protein disulfide isomerase A1 mediates endothelial dysfunction induced by angiotensin II in mice
© 2024 The Authors. Acta Physiologica published by John Wiley & Sons Ltd on behalf of Scandinavian Physiological Society..
AIM: Protein disulfide isomerases (PDIs) are involved in platelet aggregation and intravascular thrombosis, but their role in regulating endothelial function is unclear. Here, we characterized the involvement of vascular PDIA1 in angiotensin II (Ang II)-induced endothelial dysfunction in mice.
METHODS: Endothelial dysfunction was induced in C57BL/6JCmd male mice via Ang II subcutaneous infusion, and PDIA1 was inhibited with bepristat. Endothelial function was assessed in vivo with magnetic resonance imaging and ex vivo with a myography, while arterial stiffness was measured as pulse wave velocity. Nitric oxide (NO) bioavailability was measured in the aorta (spin-trapping electron paramagnetic resonance) and plasma (NO2 - and NO3 - levels). Oxidative stress, eNOS uncoupling (DHE-based aorta staining), and thrombin activity (thrombin-antithrombin complex; calibrated automated thrombography) were evaluated.
RESULTS: The inhibition of PDIA1 by bepristat in Ang II-treated mice prevented the impairment of NO-dependent vasodilation in the aorta as evidenced by the response to acetylcholine in vivo, increased systemic NO bioavailability and the aortic NO production, and decreased vascular stiffness. Bepristat's effect on NO-dependent function was recapitulated ex vivo in Ang II-induced endothelial dysfunction in isolated aorta. Furthermore, bepristat diminished the Ang II-induced eNOS uncoupling and overproduction of ROS without affecting thrombin activity.
CONCLUSION: In Ang II-treated mice, the inhibition of PDIA1 normalized the NO-ROS balance, prevented endothelial eNOS uncoupling, and, thereby, improved vascular function. These results indicate the importance of vascular PDIA1 in regulating endothelial function, but further studies are needed to elucidate the details of the mechanisms involved.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:240 |
|---|---|
| Enthalten in: |
Acta physiologica (Oxford, England) - 240(2024), 4 vom: 23. Apr., Seite e14116 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kij, Agnieszka [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 17.04.2024 Date Revised 17.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/apha.14116 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368906019 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368906019 | ||
| 003 | DE-627 | ||
| 005 | 20240417232533.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/apha.14116 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1378.xml |
| 035 | |a (DE-627)NLM368906019 | ||
| 035 | |a (NLM)38400621 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kij, Agnieszka |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Vascular protein disulfide isomerase A1 mediates endothelial dysfunction induced by angiotensin II in mice |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.04.2024 | ||
| 500 | |a Date Revised 17.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024 The Authors. Acta Physiologica published by John Wiley & Sons Ltd on behalf of Scandinavian Physiological Society. | ||
| 520 | |a AIM: Protein disulfide isomerases (PDIs) are involved in platelet aggregation and intravascular thrombosis, but their role in regulating endothelial function is unclear. Here, we characterized the involvement of vascular PDIA1 in angiotensin II (Ang II)-induced endothelial dysfunction in mice | ||
| 520 | |a METHODS: Endothelial dysfunction was induced in C57BL/6JCmd male mice via Ang II subcutaneous infusion, and PDIA1 was inhibited with bepristat. Endothelial function was assessed in vivo with magnetic resonance imaging and ex vivo with a myography, while arterial stiffness was measured as pulse wave velocity. Nitric oxide (NO) bioavailability was measured in the aorta (spin-trapping electron paramagnetic resonance) and plasma (NO2 - and NO3 - levels). Oxidative stress, eNOS uncoupling (DHE-based aorta staining), and thrombin activity (thrombin-antithrombin complex; calibrated automated thrombography) were evaluated | ||
| 520 | |a RESULTS: The inhibition of PDIA1 by bepristat in Ang II-treated mice prevented the impairment of NO-dependent vasodilation in the aorta as evidenced by the response to acetylcholine in vivo, increased systemic NO bioavailability and the aortic NO production, and decreased vascular stiffness. Bepristat's effect on NO-dependent function was recapitulated ex vivo in Ang II-induced endothelial dysfunction in isolated aorta. Furthermore, bepristat diminished the Ang II-induced eNOS uncoupling and overproduction of ROS without affecting thrombin activity | ||
| 520 | |a CONCLUSION: In Ang II-treated mice, the inhibition of PDIA1 normalized the NO-ROS balance, prevented endothelial eNOS uncoupling, and, thereby, improved vascular function. These results indicate the importance of vascular PDIA1 in regulating endothelial function, but further studies are needed to elucidate the details of the mechanisms involved | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a PDIA1 | |
| 650 | 4 | |a angiotensin II | |
| 650 | 4 | |a bepristat | |
| 650 | 4 | |a endothelial dysfunction | |
| 650 | 4 | |a oxidative stress | |
| 650 | 7 | |a Angiotensin II |2 NLM | |
| 650 | 7 | |a 11128-99-7 |2 NLM | |
| 650 | 7 | |a Protein Disulfide-Isomerases |2 NLM | |
| 650 | 7 | |a EC 5.3.4.1 |2 NLM | |
| 650 | 7 | |a Thrombin |2 NLM | |
| 650 | 7 | |a EC 3.4.21.5 |2 NLM | |
| 650 | 7 | |a Nitric Oxide Synthase Type III |2 NLM | |
| 650 | 7 | |a EC 1.14.13.39 |2 NLM | |
| 650 | 7 | |a Nitric Oxide |2 NLM | |
| 650 | 7 | |a 31C4KY9ESH |2 NLM | |
| 700 | 1 | |a Bar, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Czyzynska-Cichon, Izabela |e verfasserin |4 aut | |
| 700 | 1 | |a Przyborowski, Kamil |e verfasserin |4 aut | |
| 700 | 1 | |a Proniewski, Bartosz |e verfasserin |4 aut | |
| 700 | 1 | |a Mateuszuk, Lukasz |e verfasserin |4 aut | |
| 700 | 1 | |a Kurylowicz, Zuzanna |e verfasserin |4 aut | |
| 700 | 1 | |a Jasztal, Agnieszka |e verfasserin |4 aut | |
| 700 | 1 | |a Buczek, Elzbieta |e verfasserin |4 aut | |
| 700 | 1 | |a Kurpinska, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Suraj-Prazmowska, Joanna |e verfasserin |4 aut | |
| 700 | 1 | |a Marczyk, Brygida |e verfasserin |4 aut | |
| 700 | 1 | |a Matyjaszczyk-Gwarda, Karolina |e verfasserin |4 aut | |
| 700 | 1 | |a Daiber, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Oelze, Matthias |e verfasserin |4 aut | |
| 700 | 1 | |a Walczak, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Chlopicki, Stefan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta physiologica (Oxford, England) |d 2006 |g 240(2024), 4 vom: 23. Apr., Seite e14116 |w (DE-627)NLM160895634 |x 1748-1716 |7 nnns |
| 773 | 1 | 8 | |g volume:240 |g year:2024 |g number:4 |g day:23 |g month:04 |g pages:e14116 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/apha.14116 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 240 |j 2024 |e 4 |b 23 |c 04 |h e14116 | ||